Refine
Year of publication
Document Type
- Letter to Editor (28)
- Article (reviewed) (21)
- Article (unreviewed) (6)
- Book (4)
- Part of a Book (4)
- Conference Proceeding (4)
- Moving Images (1)
- Other (1)
- Patent (1)
Conference Type
- Konferenz-Abstract (3)
- Konferenzartikel (1)
Language
- English (70) (remove)
Has Fulltext
- no (70) (remove)
Is part of the Bibliography
- yes (70)
Keywords
- Gehirn (5)
- Götz von Berlichingen (4)
- Durchblutung (3)
- Nuklearmedizin (3)
- Trauma (3)
- Functional neuroimaging (2)
- Haaranalyse (2)
- Halswirbelsäule (2)
- Johann Sebastian Bach (2)
- Positron emission tomography (2)
Institute
- Fakultät Elektrotechnik und Informationstechnik (E+I) (bis 03/2019) (39)
- Fakultät Elektrotechnik, Medizintechnik und Informatik (EMI) (ab 04/2019) (26)
- POIM - Peter Osypka Institute of Medical Engineering (9)
- IUAS - Institute for Unmanned Aerial Systems (5)
- Fakultät Wirtschaft (W) (3)
- Fakultät Medien und Informationswesen (M+I) (bis 21.04.2021) (2)
- Fakultät Maschinenbau und Verfahrenstechnik (M+V) (1)
Open Access
- Open Access (37)
- Closed Access (13)
- Closed (4)
- Diamond (1)
In the past two decades much has been published on whiplash injury, yet both the confusion regarding the condition, and the medicolegal discussion about it have increased. In this paper, functional imaging research results are summarized using MRIcroGL3D visualization software and assembled in an image comprising regions of cerebral activation and deactivation.
In the brain-cell microenvironment, diffusion plays an important role: apart from delivering glucose and oxygen from the vascular system to brain cells, it also moves informational substances between cells. The brain is an extremely complex structure of interwoven, intercommunicating cells, but recent theoretical and experimental works showed that the classical laws of diffusion, cast in the framework of porous media theory, can deliver an accurate quantitative description of the way molecules are transported through this tissue. The mathematical modeling and the numerical simulations are successfully applied in the investigation of diffusion processes in tissues, replacing the costly laboratory investigations. Nevertheless, modeling must rely on highly accurate information regarding the main parameters (tortuosity, volume fraction) which characterize the tissue, obtained by structural and functional imaging. The usual techniques to measure the diffusion mechanism in brain tissue are the radiotracer method, the real time iontophoretic method and integrative optical imaging using fluorescence microscopy. A promising technique for obtaining the values for characteristic parameters of the transport equation is the direct optical investigation using optical fibers. The analysis of these parameters also reveals how the local geometry of the brain changes with time or under pathological conditions. This paper presents a set of computations concerning the mass transport inside the brain tissue, for different types of cells. By measuring the time evolution of the concentration profile of an injected substance and using suitable fitting procedures, the main parameters characterizing the tissue can be determined. This type of analysis could be an important tool in understanding the functional mechanisms of effective drug delivery in complex structures such as the brain tissue. It also offers possibilities to realize optical imaging methods for in vitro and in vivo measurements using optical fibers. The model also may help in radiotracer biomarker models for the understanding of the mechanism of action of new chemical entities.
Restoring hand motion to people experiencing amputation, paralysis, and stroke is a critical area of research and development. While electrode-based systems that use input from the brain or muscle have proven successful, these systems tend to be expensive and di¨cult to learn. One group of researchers is exploring the use of augmented reality (AR) as a new way of controlling hand prostheses. A camera mounted on eyeglasses tracks LEDs on a prosthetic to execute opening and closing commands using one of two different AR systems. One system uses a rectangular command window to control motion: crossing horizontally signals “open” along one direction and “close” in the opposite direction. The second system uses a circular command window: once control is enabled, gripping strength can be controlled by the direction of head motion. While the visual system remains to be tested with patients, its low cost, ease of use, and lack of electrodes make the device a promising solution for restoring hand motion.
Neuroprosthetics 2.0
(2019)
Method for controlling a device, in particular, a prosthetic hand or a robotic arm (US20200327705A1)
(2020)
A method for controlling a device, in particular a prosthetic hand or a robotic arm, includes using an operator-mounted camera to detect at least one marker positioned on or in relation to the device. Starting from the detection of the at least one marker, a predefined movement of the operator together with the camera is detected and is used to trigger a corresponding action of the device. The predefined movement of the operator is detected in the form of a line of sight by means of camera tracking. A system for controlling a device, in particular a prosthetic hand or a robotic arm, includes a pair of AR glasses adapted to detect the at least one marker and to detect the predefined movement of the operator.
A survey in 2000 revealed that only about 30% of the prescriptions in the European pediatric population were on the basis of evidence-based medicine (EbM). Less for radiopharmaceuticals and principally for diagnostics, radiologists throughout Europe are referred to the pediatric guidelines of the European Association of Nuclear Medicine (EANM), as none of the frequently used tracers have been evaluated in clinical trials in the different pediatric subgroups. Following a resolution to address the lack of EbM in children, the European Commission published the Pediatric Regulation EC 1901/2006 and its amendment EC 1902/2006, effective from 2007. This regulation foresees the development of evidence-based medicine in the pediatric population. This is effected through a set of principles like the mandatory pediatric investigation plan (PIP) to be included with the market authorization application (MAA), and the pediatric use market authorization (PUMA) for off-patent pharmaceuticals, and to a very small part radiopharmaceuticals with funding possibilities for pediatric-specific research through the 7th Framework Programme (7FP) of the European Union.